Navigation Links
Researchers design drug to restore cell suicide in HPV-related head and neck cancer
Date:4/8/2013

the function of the p53 "tumor-suppressor" gene and triggers the death of the cancer cells.

"Our study revealed a new mechanism for p53 inactivation in HPV-positive head and neck cancer, and this allowed us to develop an agent that disrupts that interaction and reactivates p53 in HPV-positive head and neck cancer," Pan says. "Our pre-clinical studies show CH1iB can reactivate p53 and eliminate HPV-positive head and neck cancer cells."

Pan notes that the standard of care for HPV-positive head and neck cancer uses high-dose cis-platinum, a chemotherapy drug that causes serious side effects that are difficult for patients to tolerate. The drug's toxicity raises the need for safer therapy, and, although further testing is necessary, combining CH1iB with a low dose of cis-platinum might one day provide an alternative.

For this study, Pan and his colleagues used high-risk HPV-positive head and neck squamous cell carcinoma cells. Key technical findings include:

  • The small-molecule inhibitor CH1iB inhibits the binding of the HPV E6 protein with the p300 cell protein;

  • The binding of the CH1iB inhibitor with p300 reactivated p53 and dramatically potentiated the efficacy of cis-platinum in HPV-positive head and neck cancer cells.

  • The combination of CH1iB and cis-platinum eliminated 91 percent of HPV16-positive head and neck cancer cells; it also increased apoptosis by 984 percent and 443 percent compared with CH1iB and cis-platinum respectively alone.

"These results suggest that fewer cycles or a tapered dose of cis-platinum, along with a CH1 inhibitor, might be sufficient to effectively manage HPV-positive head and neck cancer patients and offer a better toxicity profile," Pan says.

"Taken together, our data suggest that we've discovered a novel approach for reactivating the p53 gene in HPV-positive head and neck cancer that may translate to other HPV-positive carcinomas."


'/>"/>

Contact: Darrell E. Ward
darrell.ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers shine light on how stress circuits learn
2. Cleveland Clinic researchers discover new link between heart disease and red meat
3. SFU researchers help unlock pine beetles Pandoras box
4. Empa researchers join Quantis to open new branch in Switzerland
5. MDC and FMP researchers identify edema inhibitor
6. Barrow researchers identify
7. Researchers discover brain cancer treatment using genetic material from bone marrow cells
8. Notre Dame researchers are using new technologies to combat invasive species
9. University of Montreal researchers discover how drug prevents aging and cancer progression
10. Researchers question evaluation methods for protected areas in the Amazon
11. Penn Researchers attach Lyme disease antibodies to nanotubes, paving way for diagnostic device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... eight hundred births, Down syndrome - or trisomy 21 ... disability. It results from a chromosomal abnormality where cells ... 21 (1% of the human genome). A study conducted ... of Genetic Medicine and Development at the University of ... , shed light on how the extra chromosome 21 ...
(Date:4/17/2014)... Singh Thursday as a "Champion of Change" for ... in the residential, commercial and industrial sectors. , ... and Computer Engineering and director of Clemson,s Center ... leading the charge across the country to create ... driving policy changes at the local level to ...
(Date:4/17/2014)... implicated in many serious conditions such as heart disease, ... for drug therapies. Unfortunately, there is still much scientists ... provides fresh and unexpected insight into the structure of ... β-subunit molecules - which are responsible for ,fine-tuning, the ... the most recent edition of the Journal of ...
Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2
... , ,Mathematical models continue to play a major ... and control of malaria, a life-threatening parasitic disease ... Although existing models have advanced our understanding of ... new challenges., The National Institute for Mathematical and ...
... JOLLA, CA January 18, 2011 Using chemical compounds ... clever application of ultraviolet light, a Scripps Research Institute team ... to test for biomedical potential. Already, one of the compounds ... and fighting inflammation. With the report of their ...
... how the hormones progesterone and estrogen interact to increase ... a novel finding that may explain why postmenopausal women ... at increased risk of breast cancer. The discovery ... the increased production of the protein amphiregulin, which binds ...
Cached Biology News:Malaria modeling and control focus of workshop 2Scripps Research team creates new synthetic compound with HIV-fighting promise 2Scripps Research team creates new synthetic compound with HIV-fighting promise 3Researchers unlock how progesterone increases breast cancer risk 2
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014 ... two institutes from the National Institutes of Health (NIH) ... safer, more effective treatments to patients on a faster ... Advancing Translational Sciences (NCATS) and the National Eye Institute ...
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ...
(Date:1/14/2014)... and Cardiff, UK (PRWEB) January 13, 2014 ... development leader with more than 20 years in the ... optics and photonics . Hainsey will serve as the ... to have Dr. Hainsey join SPIE as our Technology ...
Breaking Biology Technology:Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... Thera, Inc.,announced today that the United States Patent ... "Protein-fragment Complementation,Assays (PCA) in whole animals: applications to ... gene therapy." This is the,twelfth patent issued for ... a method for detecting protein-protein,interactions in living cells ...
... Dec. 12 Genaera,Corporation (Nasdaq: GENR ) today ... Genaera, is scheduled to present at the 2007,RBC Capital ... Capital Markets, panel discussion of diabetes and obesity, entitled,"The ... place in,New York on Thursday, December 13 at 10:00 ...
... (OTC,Bulletin Board: BMOD) ( http://www.biomoda.com ) of Albuquerque, ... (New Mexico Tech at, http://www.nmt.edu ) reached an ... development of specialized image recognition technology as,part of ... early,detection of lung cancer., New Mexico Tech, ...
Cached Biology Technology:Odyssey Thera Granted U.S. Patent for Animal Imaging 2Biomoda Announces Collaborative Agreement With New Mexico Tech 2